Literatur > Priv.‑Doz. Dr. med. Dr. Andreas Eggert
zurück

  • Schrama D, Voigt H, Eggert AO, Xiang R, Zhou H, Schumacher TN, Andersen MH,Thor Straten P, Reisfeld RA, Becker JC. Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunol Immunother. 2008 Jan; 57(1):85-95.
  • Wobser M, Voigt H, Eggert AO, Houben R, Kauczok CS, Bröcker EB, Becker JC. Bcl-2 expression in rituximab refractory cutaneous B-cell lymphoma. Br J Cancer. 2007 May 21; 96(10):1540-3.
  • Wobser M, Voigt H, Houben R, Eggert AO, Freiwald M, Kaemmerer U, Kaempgen E, Schrama D, Becker JC. Dendritic cell based antitumor vaccination: impact of functional indoleamine 2,3-dioxygenase expression. Cancer Immunol Immunother. 2007 Jul; 56(7):1017-24.
  • Voigt H, Schrama D, Eggert AO, Vetter CS, Müller-Blech K, Reichardt HM, Andersen MH, Becker JC, Lühder F. CD28-mediated costimulation impacts on the differentiation of DC vaccination-induced T cell responses. Clin Exp Immunol. 2006 Jan; 143(1):93-102.
  • Douillard P, Stoitzner P, Tripp CH, Clair-Moninot V, Aït-Yahia S, McLellan AD, Eggert A, Romani N, Saeland S. Mouse lymphoid tissue contains distinct subsets of langerin/CD207 dendritic cells, only one of which represents epidermal-derived Langerhans cells. J Invest Dermatol. 2005 Nov; 125(5):983-94.
  • Eggert AO, Grunewald S, Müller I, Lempert S, Bröcker EB, Goebeler M. [Chronic favus caused by infection with Trichophyton schönleinii] J Dtsch Dermatol Ges. 2004 Oct;2(10):855-7.
  • Eggert AO, Wössner R, Knoll A, Hamm H, Wanner C, Breunig FB. Umbilical angiectases as the sole clinical sign of Fabry disease in a 9-year-old boy. Eur J Pediatr. 2006 Mar; 165(3):205-6.
  • Schrama D, Voigt H, Eggert AO, Xiang R, Reisfeld RA, Becker JC. Therapeutic efficacy of tumor-targeted IL2 in LTalpha(-/-) mice depends on conditioned T cells. Cancer Immunol Immunother. 2006 Jul; 55(7):861-6.
  • Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC. Stromal cells as the major source for matrix metalloproteinase-2 in cutaneous melanoma. Arch Dermatol Res. 2005 Oct; 297(4):154-60.
  • Otto K, Andersen MH, Eggert A, Keikavoussi P, Pedersen LØ, Rath JC, Böck M, Bröcker EB, Straten PT, Kämpgen E, Becker JC. Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin. Vaccine. 2005 Jan 4; 23(7):884-9.
  • Eggert AO, Andersen MH, Voigt H, Schrama D, Kämpgen E, Straten PT, Becker JC. Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes. Eur J Immunol. 2004 Nov; 34(11):3285-90.
  • Schrama D, Xiang R, Eggert AO, Andersen MH, Pedersen Ls LØ, Kämpgen E, Schumacher TN, Reisfeld RR, Becker JC. Shift from systemic to site-specific memory by tumor-targeted IL-2. J Immunol. 2004 May 15; 172(10):5843-50.
  • Hofmann UB, Eggert AA, Blass K, Bröcker EB, Becker JC. Expression of matrix metalloproteinases in the microenvironment of spontaneous and experimental melanoma metastases reflects the requirements for tumor formation. Cancer Res. 2003 Dec 1; 63(23):8221-5.
  • Weyandt GH, Eggert AO, Houf M, Raulf F, Bröcker EB, Becker JC. Anorectal melanoma: surgical management guidelines according to tumour thickness. Br J Cancer. 2003 Dec 1; 89(11):2019-22.
  • Eggert AA, van der Voort R, Torensma R, Moulin V, Boerman OC, Oyen WJ, Punt CJ, Diepstra H, de Boer AJ, Figdor CG, Adema GJ. Analysis of dendritic cell trafficking using EGFP-transgenic mice. Immunol Lett. 2003 Oct 9; 89(1):17-24.
  • Leverkus M, McLellan AD, Heldmann M, Eggert AO, Bröcker EB, Koch N, Kämpgen E. MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways. Int Immunol. 2003 Aug; 15(8):993-1006.
  • Schrama D, Eggert AA, Bröcker EB, Pedersen LO, thor Straten P, Becker JC. Immunological consequences of the sentinel lymph-node biopsy--lessons from a melanoma patient. Lancet Oncol. 2003 Jul; 4(7):446-7.
  • Hofmann UB, Eggert AA, Bröcker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. Br J Dermatol. 2003 Apr; 148(4):779-83.
  • Breunig F, Weidemann F, Beer M, Eggert A, Krane V, Spindler M, Sandstede J, Strotmann J, Wanner C. Fabry disease: diagnosis and treatment. Kidney Int Suppl. 2003 May; (84):S181-5.
  • Kämmerer U, Eggert AO, Kapp M, McLellan AD, Geijtenbeek TB, Dietl J, van Kooyk Y, Kämpgen E. Unique appearance of proliferating antigen-presenting cells expressing DC-SIGN (CD209) in the decidua of early human pregnancy. Am J Pathol. 2003 Mar; 162(3):887-96.
  • de Vries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG. Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother (1997). 2002 Sep-Oct; 25(5):429-38.
  • Kirst A, Wack C, Lutz WK, Eggert A, Kämpgen E, Fischer WH. Expression of functional kappa-opioid receptors on murine dendritic cells. Immunol Lett. 2002 Oct 21; 84(1):41-8.
  • McLellan AD, Kapp M, Eggert A, Linden C, Bommhardt U, Bröcker EB, Kämmerer U, Kämpgen E. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression. Blood. 2002 Mar 15; 99(6):2084-93.
  • Eggert AO, Becker JC, Ammon M, McLellan AD, Renner G, Merkel A, Bröcker EB, Kämpgen E. Specific peptide-mediated immunity against established melanoma tumors with dendritic cells requires IL-2 and fetal calf serum-free cell culture. Eur J Immunol. 2002 Jan; 32(1):122-7.
  • Wagener FA, Eggert A, Boerman OC, Oyen WJ, Verhofstad A, Abraham NG, Adema G, van Kooyk Y, de Witte T, Figdor CG. Heme is a potent inducer of inflammation in mice and is counteracted by hemeoxygenase. Blood. 2001 Sep 15; 98(6):1802-11.
  • Schreurs MW, Eggert AA, de Boer AJ, Vissers JL, van Hall T, Offringa R, Figdor CG, Adema GJ. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model. Cancer Res. 2000 Dec 15; 60(24):6995-7001.
  • Schreurs MW, Eggert AA, Punt CJ, Figdor CG, Adema GJ. Dendritic cell-based vaccines: from mouse models to clinical cancer immunotherapy. Crit Rev Oncog. 2000; 11(1):1-17.
  • Schreurs MW, Eggert AA, de Boer AJ, Figdor CG, Adema GJ. Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur J Immunol. 1999 Sep; 29(9):2835-41.
  • Eggert AA, Schreurs MW, Boerman OC, Oyen WJ, de Boer AJ, Punt CJ, Figdor CG, Adema GJ. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 1999 Jul 15; 59(14):3340-5.
  • Kämpgen E, Koch F, Heufler C, Eggert A, Gill LL, Gillis S, Dower SK, Romani N, Schuler G. Understanding the dendritic cell lineage through a study of cytokine receptors. J Exp Med. 1994 Jun 1; 179(6):1767-76.